首页 | 本学科首页   官方微博 | 高级检索  
     


Effects of ginsenoside compound K combined with cisplatin on the proliferation,apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer
Authors:Keqiang Zhang
Affiliation:The Medical Department in Second Hospital of Jilin University, Changchun, PR China
Abstract:Context: Breast cancer seriously harms the health of women and there are currently few therapeutic options for patients with breast cancer.

Objective: Effects of ginsenoside compound K (CK) in combination with cisplatin (DDP) on the proliferation, apoptosis, and epithelial mesenchymal transition (EMT) of MCF-7 cells were studied.

Materials and methods: MCF-7 cells were divided into CK (50?μmol/L) group, DDP (10?mg/L) group, CK (50?μmol/L)?+DDP (10?mg/L) group, and control (CON) group. The cells in the CON group were not treated with any drugs. Proliferation, apoptosis, expression of E-cadherin, N-cadherin, vimentin, protein kinase B (Akt), phosphorylated Akt (p-Akt), and level of fibronectin (FN) in MCF-7 cells were detected by methyl thiazolyl tetrazolium (MTT), flow cytometry, western blotting, and enzyme-linked immuno sorbent assay (ELISA), respectively.

Results: The proliferation inhibition rates in CK, DDP, and CK?+?DDP groups at 48?h were 19.18?±?2.25, 21.34?±?2.84, and 43.37?±?5.62, respectively. The apoptosis rates were 2.85?±?0.56, 13.37?±?2.28, 20.04?±?2.92, and 30.78?±?4.64 at 24?h and 3.14?±?0.72, 20.36?±?3.28, 27.58?±?4.09, and 41.62?±?5.83 at 48?h in CON, CK, DDP, and CK?+?DDP groups, respectively. CK or DDP alone and their combination all could reduce the levels of N-cadherin, vimentin, p-Akt/Akt, and FN and elevate level of E-cadherin.

Discussion and conclusion: Both CK and DDP can inhibit the proliferation, EMT, and induce the apoptosis in MCF-7 cells, which may be related to the PI3K/Akt pathway. In addition, the combination of CK with DDP can produce a better effect.
Keywords:Anticancer  carcinoma  PI3K/Akt pathway
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号